Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3

University of Wisconsin (UW)

Status: Completed

Conditions: Drug Use Disorders; Opioid-use Disorder; Hepatitis C; Harm Reduction

Treatments: Other: Community-Based, Client-Centered Prevention Home

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04268173

SMPH/MEDICINE/INFECT DIS (Other Identifier)

Protocol Version 2/1/2023 (Other Identifier)

UH3DA044826 (U.S. NIH Grant/Contract)

2017-0866

A534265 (Other Identifier)

Details and patient eligibility

About

The goal of this study was to effectively use a client-centered community-based intervention to engage people who inject drugs (PWIDs) in healthcare that helps reduce risky behaviors and lower infectious disease risks. Participants in the intervention group of this study received a 12-week intensive multilevel harm reduction case-management intervention at three rural Vivent Health offices. Service coordination aimed to reduce human immunodeficiency virus (HIV), hepatitis C virus (HCV), and overdose risks in PWIDs. Prevention Navigators (PNs) at each office helped to coordinate referrals to reduce substance use disorder and increase engagement in the substance use disorder care cascades.

Full description

This project was conducted by an experienced, interdisciplinary team working across academic, public health, and non-government sectors. The main community partner Vivent Health, formerly known as the AIDS Resource Center of Wisconsin (ARCW), is a unique, state-wide organization that provides harm reduction services, including syringe services and confidential HIV and HCV testing, to clients at 10 fixed sites and numerous mobile units reaching all 72 Wisconsin counties. Based on the investigators' preliminary studies and prior collaborations, the investigators selected 6 counties in rural Wisconsin. The Client-Centered Prevention Home intervention model was implemented at 3 Vivent Health field offices in 3 of these counties, and 3 other counties served as "usual services," or control sites. Participants in the intervention underwent a 12-week intensive multilevel harm reduction case-management intervention geared towards coordinating referrals to reduce substance use disorder and increase engagement in the substance use disorder care cascades, and reduce vulnerability to HIV, STIs, and HCV and increase in engagement in the HIV, STI, and HCV care cascades. Participants in the intervention arm worked with Prevention Navigators to undergo a risk assessment and identify problems and create goals that they want to achieve. Each session after that was used to review the needs assessment and goals. During their last meeting, participants and prevention navigators developed a discharge plan that will enable the participants to work on their goals on their own. Participants at all six sites were offered rapid testing for HIV, HCV, and STIs, and fill out survey questionnaires to evaluate risk behaviors, intervention effectiveness, and general needs of the communities.

Enrollment: 343 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• has injected drugs in the past 30 days, resides in Wisconsin, over 18 years of age
• able to read and write in English

Exclusion criteria

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

343 participants in 2 patient groups

Prevention Navigation

Experimental group

Description:

Participants enrolled in this arm will receive a 12-week community-based, client-centered, prevention intervention.

Treatment:

Other: Community-Based, Client-Centered Prevention Home

Usual Services

No Intervention group

Description:

Participants enrolled in this arm will receive services as usual from Vivent Health and will not engage in the intervention.